|
|
|
Press Releases
MILESTONE SCIENTIFIC SIGNS SUPPLY AND DISTRIBUTION AGREEMENT
WITH UTAH MEDICAL PRODUCTS FOR COMPUMED®
Piscataway, N.J. – (PR NEWSWIRE) – December
1, 2009 – Milestone Scientific Inc. (OTCBB:MLSS),
the recognized leader in advanced injection technologies, today announced
that it has signed a non-exclusive Supply and Distribution Agreement
with Utah Medical Products, Inc. (Nasdaq: UTMD), granting them rights
to market and sell Milestone’s proprietary CompuMed® computer-controlled
injection system to its North American customer base.
Kevin Cornwell, Chief Executive Officer of UTMD, stated, “We believe
the CompuMed system fits well with UTMD’s focus to provide
specialized, clinically effective solutions for women’s health
care, especially for the surgical management of [uterine] cervical disease.”
With particular interest in health care for women and their babies,
Utah Medical Products (www.utahmed.com) develops, manufactures,
assembles and markets a broad range of well-established disposable and
reusable specialty medical devices designed for better health outcomes
for patients and their care providers.
Leonard Osser, Chief Executive Officer of Milestone, noted, “A
key component to our long term growth strategy is building a strong,
capable distribution network to actively market and sell Milestone’s
innovative computer-controlled injection technologies to both medical
and dental practitioners worldwide. We are very pleased to be teaming
with Utah Medical Products and look forward to working with them to heighten
awareness in the medical community of CompuMed’s many
noted benefits– not the least of which is providing for painless
injections.”
CompuMed is a patented computer-controlled injection system
geared to the needs of the medical market and allows many medical procedures, now requiring IV sedation, to be performed with only local
anesthesia due to dramatic pain reduction. Also, dosages
of local anesthetic can often be significantly reduced, thus reducing side
effects, accelerating recovery times, lowering costs
and eliminating potential complications. CompuMed has
gained clinical evidence demonstrating benefits from use in colorectal
surgery; podiatry; dermatology, including surgery for the removal of
basal cell carcinomas and other oncological dermatologic procedures;
nasal and sinus surgery, including rhinoplasty; hair transplantation
and plastic surgery, among others.
About Milestone Scientific Inc.
Headquartered in Piscataway, New Jersey, Milestone Scientific is engaged
in pioneering proprietary, highly innovative technological solutions
for the medical and dental markets. Central to the Company’s
IP platform and product development strategy is its patented CompuFlo® technology
for the improved and painless delivery of local anesthetic. Specifically, CompuFlo is
a computer-controlled, pressure sensitive infusion, perfusion, suffusion
and aspiration technology, which provides real-time readouts of pressures,
fluid densities and flow rates, enabling the advanced delivery and
removal of a wide array of fluids. The STA Single
Tooth Anesthesia System™, a computer-controlled local anesthesia
delivery system, uses this technology to provide dentists with audible
and visual signals as to in-tissue pressure. Milestone’s
existing painless injection systems are currently sold in 25 countries. For
more information on these and other innovative Milestone products,
please visit the Company’s web site found at www.milestonescientific.com and www.STAis4U.com.
FOR MORE INFORMATION, PLEASE CONTACT:
Elite Financial Communications Group
Dodi Handy, President and CEO
For Media Inquiries: Tiffany Korkis or Kathy Addison, Directors, Elite
Media Group
407-585-1080 or via email at mlss@efcg.net
|
